Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs Viz HCM

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Acumen Hypotension Prediction Index – EV1000 Clinical Platform
by Edwards Lifesciences
VS
Viz HCM
by Viz.ai

AI Verdict

Tool A focuses on predicting and managing acute hypotensive events using continuous hemodynamic monitoring, primarily for intraoperative and critical care settings. In contrast, Tool B leverages AI to detect Hypertrophic Cardiomyopathy from ECGs and streamline care coordination for this specific cardiac disease. While both operate within cardiology and emergency medicine, they address different clinical problems and utilize distinct data inputs for their respective functions.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose the Acumen Hypotension Prediction Index if your primary goal is to proactively prevent and manage intraoperative or critical care hypotension. This tool is ideal for anesthesiologists and critical care teams needing real-time, continuous hemodynamic monitoring and predictive insights to intervene before hypotensive events occur. It helps optimize patient stability by providing early warnings and actionable data on hemodynamic instability.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose Viz HCM if…

Choose Viz HCM if your institution aims to significantly reduce the time to diagnosis and treatment for Hypertrophic Cardiomyopathy (HCM). This AI-powered solution is best suited for cardiology and emergency departments seeking to rapidly detect suspected HCM from real-time ECG analysis and automatically coordinate care with appropriate specialists. It streamlines workflows for a specific cardiac condition, ensuring timely patient management.

View Viz HCM →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Viz HCM
Pricing Unknown Subscription-based
Deployment On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) Cloud-based platform, integrated into hospital IT systems (EHR, PACS).
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz HCM

Viz HCM (Tool B) offers a cloud-based platform with seamless integration into existing hospital IT systems like EHR and PACS, alongside mobile-based alerts. This broad integration and mobile accessibility likely provide a more flexible and accessible user experience for multidisciplinary care teams. While Acumen HPI (Tool A) is integrated with a specific monitoring platform, its reliance on dedicated hardware might limit its overall usability footprint compared to a cloud-native, mobile-enabled solution.

Clinical Value

Viz HCM

Both tools offer significant clinical value, being FDA-cleared and addressing critical patient needs. However, Viz HCM (Tool B) not only detects Hypertrophic Cardiomyopathy but also provides 'intelligent care coordination' and 'automated direction of patients to appropriate care specialists,' which extends its impact beyond diagnosis to streamlining the entire care pathway. Furthermore, Tool B explicitly highlights 'extensive real-world evidence and publications' supporting its clinical validation, which strengthens its clinical value proposition.

Pricing & Value

Viz HCM

Viz HCM (Tool B) provides greater transparency regarding its pricing model, stating it is subscription-based and, critically, mentioning CMS reimbursement availability for specific CPT codes with a national payment rate. This clear path to reimbursement significantly enhances its financial value for healthcare providers. Acumen HPI (Tool A) only states 'contact-for-pricing,' offering no immediate insight into potential costs or return on investment.

Enterprise Readiness

Viz HCM

Both tools are HIPAA compliant and FDA cleared, indicating a baseline for enterprise use. However, Viz HCM (Tool B) is a cloud-based platform designed for integration with existing hospital IT systems (EHR, PACS) and explicitly states it has a Business Associate Agreement (BAA). This architecture and explicit BAA make it highly adaptable and scalable for enterprise-wide deployment across diverse clinical settings. Acumen HPI (Tool A)'s deployment is tied to a specific monitoring platform and dedicated sensors, which may present more integration challenges in a broader enterprise context.

Innovation

Viz HCM

While Acumen HPI (Tool A) innovatively uses machine learning for proactive hypotension prediction, Viz HCM (Tool B) demonstrates a broader scope of innovation. Tool B not only leverages AI for real-time disease detection from ECGs but also extends its capabilities to 'intelligent care coordination' and 'automated direction of patients to appropriate care specialists.' This holistic approach, integrating detection with workflow optimization and patient management, represents a more comprehensive and impactful innovation in care delivery.

Support & Docs

Tie

Neither the provided structured facts nor readily available public information offer specific details regarding the depth, availability, or quality of support and documentation for either Acumen HPI (Tool A) or Viz HCM (Tool B). Without comparative data on these aspects, it is not possible to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Viz HCM
Tool Name Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform Viz HCM
Company Edwards Lifesciences Viz.ai
Description The Acumen Hypotension Prediction Index (HPI) software by Edwards Lifesciences uses machine learning to predict hypotensive events up to 15 minutes in advance, providing clinicians with insights into hemodynamic instability and potential causes to help reduce intraoperative hypotension. Viz HCM is an FDA-cleared AI tool by Viz.ai that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time.
Primary Function Predicts hypotensive events up to 15 minutes in advance and provides insights into hemodynamic instability. Detects suspected Hypertrophic Cardiomyopathy (HCM) using real-time ECG analysis and coordinates cardiac care.
Key Features (Examples) HPI Parameter (0-100 likelihood score), Smart Alerts for trending hypotension, Predicts hypotension up to 15 minutes in advance. AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection, Real-time disease detection from electrocardiograms, Mobile-based alerts and notifications.

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and Viz HCM.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI integrates with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform, providing real-time predictions of hypotension and insights into hemodynamic instability to help clinicians reduce intraoperative hypotension. Viz HCM integrates with EHR and PACS systems, using real-time ECG analysis to detect suspected HCM and coordinate care, aiming to significantly reduce diagnosis time and streamline cardiac care.
Acumen HPI is integrated with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform, which records vitals and the predictive index, and can feed data into the EHR, providing continuous hemodynamic monitoring. Viz HCM offers seamless integration with existing clinical workflows, EHR, and PACS systems, facilitating automated direction of patients to appropriate care specialists and providing a comprehensive patient view with EMR-enhanced insights.
Acumen HPI uses a machine learning-based algorithm to predict hypotension up to 15 minutes in advance, with studies showing high predictive performance and a significant reduction in the duration of intraoperative hypotension. Viz HCM is clinically validated with extensive real-world evidence and publications, demonstrating high accuracy in detecting HCM from ECGs and significantly accelerating diagnosis time.
Acumen HPI, designed for Anesthesiology, Critical Care, and Emergency Medicine, provides a HPI Parameter score, Smart Alerts, and a Relationship View screen to aid in interpreting hemodynamic insights and understanding the root cause of instability. Viz HCM, targeting Cardiology, Emergency Medicine, and Hospital Medicine, offers mobile-based alerts and automated patient direction, streamlining the process of HCM detection and care coordination through AI-powered ECG analysis.
Acumen HPI requires integration with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform via dedicated sensors (Acumen IQ cuff or sensor), implying specific hardware and infrastructure dependencies for multi-site deployment. Viz HCM is a cloud-based platform integrated into hospital IT systems (EHR, PACS), suggesting a more software-centric rollout that would focus on IT system compatibility and network infrastructure across sites, with studies evaluating its implementation into diverse clinical workflows.
The provided information for Acumen HPI does not explicitly detail audit-trail features or security measures beyond standard compliance, but it operates within a dedicated clinical monitoring platform. Viz.ai has completed SOC 2 Type II + HIPAA audits, validating its adherence to security, availability, processing integrity, confidentiality, and privacy principles for its cloud systems, which includes controls for managing customer data.
Acumen HPI aims to help reduce intraoperative hypotension by predicting events up to 15 minutes in advance, offering immediate clinical insights, with studies demonstrating reduced duration and severity of hypotension. Viz HCM is designed to significantly reduce diagnosis time for HCM, with real-world studies showing it can identify new HCM patients faster and streamline care pathways, and its clinical validation is supported by extensive real-world evidence and publications.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform or Viz HCM

Backers

Who funded each tool's parent company.

Viz HCM

AI Tool Finder
AI-powered search. Results may not be comprehensive.